Literature DB >> 11737368

Penetration of HIV-1 protease inhibitors into CSF and semen.

S Taylor1, A Pereira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11737368     DOI： 10.1046/j.1468-1293.2000.00002.x

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  4 in total

1.  Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography.

Authors:  Michele Di Mascio; Sharat Srinivasula; Abesh Bhattacharjee; Lily Cheng; Lucia Martiniova; Peter Herscovitch; Juan Lertora; Dale Kiesewetter
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

2.  Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1.

Authors:  Jörn Lötsch; Sebastian Harder; Martin Stürmer; Hans-Wilhelm Doerr; Gerd Geisslinger; Schlomo Staszewski; Nils von Hentig
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

3.  Identification of a potential pharmacological sanctuary for HIV type 1 in a fraction of CD4(+) primary cells.

Authors:  Antonio Valentin; Matthew Morrow; Richard H Poirier; Karen Aleman; Richard Little; Robert Yarchoan; George N Pavlakis
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

4.  Enantiomeric radiochemical synthesis of R and S (1-(6-amino-9H-purin-9-yl)-3-fluoropropan-2-yloxy)methylphosphonic acid (FPMPA).

Authors:  Dale O Kiesewetter; Kathleen Knudson; Matt Collins; Sharat Srinivasula; Esther Lim; Michele Di Mascio
Journal:  J Labelled Comp Radiopharm       Date:  2008-03-13       Impact factor: 1.921
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.